Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
NCT03237481
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
418
Enrollment
INDUSTRY
Sponsor class
Conditions
Postoperative Pain
Interventions
DRUG:
HTX-011
DRUG:
Bupivacaine HCl
DRUG:
Saline placebo
DEVICE:
Luer-lock applicator
DEVICE:
Vial access device
Sponsor
Heron Therapeutics